Pro forma equity value
$638M
vs. ~$1M trailing revenue → ~600× sales multiple
Enterprise value
$370M
implied by deal mechanics
Gross proceeds (up to)
$251.7M
$176.7M McKinley trust + $75M PIPE
Negotiating 5-yr contracts
~$35M
vs. existing annual awards of $300K–$400K
The deal mechanics
A $638M SPAC on $1M of revenue prices narrative, not cash flow
Space-Eyes, a Miami-based counter-drone and geospatial-intelligence firm, agreed on July 31, 2026 to merge with McKinley Acquisition Corp (Nasdaq: MKLYU) at a pro forma equity value of $638M and an enterprise value of $370M, per Reuters reporting. The post-merger company will trade on Nasdaq under the ticker CUAS, pending close in Q4 2026. McKinley's $150M IPO (priced August 12, 2025 at $10 per unit, 100% in trust) supplies up to $176.7M of cash, with up to $75M more from a PIPE structured as senior secured convertible notes at 10% maturing 2031.
The pipeline the SPAC is pricing is real but unsigned. Space-Eyes is currently negotiating contracts worth about $35M over five years for counter-drone, Caribbean drug-trafficking monitoring, Middle East defense work, and U.S. prison contraband interdiction — against existing annual awards of just $300,000 to $400,000. Reuters' $1M trailing-revenue figure is consistent with the company having ~35 employees (per The Next Web) and the products it sells: SeaWatch (maritime intelligence), Morpheus (RF-based counter-drone C-UAS), and FireWatch, all built around a proprietary CATE AI fusion engine.
Why the market is paying
Eric Trump turns affiliation into a Pentagon-door key
Eric Trump recently became the third-largest private investor in Space-Eyes and will serve as a strategic adviser to the combined business, where he has helped introduce board candidates. Bloomberg Law describes the deal as at least the fourth Trump-sons drone investment since the 2024 election. Space-Eyes opened a Washington office in January 2026 to deepen government partnerships — a fast move from a 35-person Miami firm, and one that the CUAS announcement casts as the reason this startup, not a private capital raise, is the venue.
The Washington Post's July 13, 2026 investigation tallied $3.2B in direct government contracts and $3.1B in future contract options flowing to companies the Trump sons invested in since the election — with SpaceX and Anduril accounting for 97% of direct cash and 42% of option value. Excluding those two, 13 other Trump-affiliated startups have captured nearly $1.8B in long-term federal commitments and $103M in direct cash. 1789 Capital, the Donald Trump Jr.–affiliated firm that has posted 200% returns, holds roughly $3B AUM and invested in 11 of the 15 defense/robotics/AI names with Pentagon business.
Supply-chain linkage
Space-Eyes sits in the counter-UAS bottleneck between primes and component makers
Space-Eyes targets the counter-UAS software-fusion layer — a market independent third parties size at $12.6B in 2026, rising to $24.1B by 2030 (CAGR ~18%, per Unmanned Airspace) and $55.25B by 2034 (Fortune Business Insights, 22.4% CAGR). Its Morpheus system uses RF detection rather than radar, putting it closer to where Kratos Defense & Security Solutions (KTOS) plays in tactical unmanned systems than to where AeroVironment (AVAV) plays in kinetic interceptors. AeroVironment's counter-UAS business already produced about $200M of FY26 revenue (per Motley Fool), with management targeting $3.5B–$4B in total revenue by FY30.
Upstream of Space-Eyes' fusion engine sit the RF sensor and AI-compute suppliers, where Unusual Machines (UMAC) — a Trump Jr.–linked NDAA-compliant drone-component maker — holds positioning. UMAC secured a $12.8M Army order for ~160,000 drone components in October 2025 and made a $30M strategic equity investment in Powerus. Downstream, the operators are the same agencies Space-Eyes is pitching: the Department of Homeland Security for Caribbean monitoring, the Department of Defense for Middle East work, and the Bureau of Prisons for interdiction.
| Company | Ticker | Mkt Cap | TTM Revenue | Defense Linkage |
|---|---|---|---|---|
| Kratos Defense | KTOS | $8.68B | $1.42B | Unmanned Systems + turbine tech, DoD prime |
| AeroVironment | AVAV | $7.56B | $1.98B | Counter-UAS, Switchblade, JUMP 20 |
| Ondas Holdings | ONDS | $4.20B | $96.6M | Scout Drone + FullMAX SDR, 4M Defense |
| Unusual Machines | UMAC | $691M | $17.3M | NDAA-compliant drone components, Army |
| XTEND (via JFB) | JFB | n/d | n/d | $1.5B merger, Pentagon Drone Dominance Phase II |
Comparable transactions
Two Trump-sons precedents already printed — Space-Eyes is the third
XTEND's $1.5B all-stock merger with JFB Construction Holdings (announced February 17, 2026; re-announced July 27, 2026 at $1.5B for XTEND AI Robotics, ticker XTND) raised $152M in pre-IPO capital with Eric Trump as a strategic investor. XTEND advanced into Phase II of the Pentagon's $1B Drone Dominance Program in June 2026 — meaningful validation that arrived before its Nasdaq debut.
Powerus completed a reverse merger with Aureus Greenway Holdings (Nasdaq: JFB) on March 9, 2026 at a multi-hundred-million valuation, with both Trump sons as investors. The U.S. Air Force agreed to buy an undisclosed number of Powerus drone interceptors in May 2026. The combined pattern: small-cap drone names, family-affiliated capital, public-market access via SPAC or reverse merger, and a Pentagon contract that lands within months.
Trump-family–affiliated defense SPAC/reverse-merger transactions
Equity-value disclosures for the three public deals through July 2026
Unit: USD millions
XTEND / JFB
$1.5B all-stock; Feb 2026
1,500
Powerus / Aureus
Reverse merger; Mar 2026
350
Space-Eyes / McKinley
$638M pro forma equity; Jul 2026
638
What moves next
Short-term catalysts vs. the structural Trump-premium question
- Short-term (Q4 2026 → Q1 2027): Space-Eyes must close the McKinley merger, sign the $35M of negotiating contracts, and survive any McKinley shareholder redemptions out of the $176.7M trust. Redemption rates above 60% would compress CUAS float and could force the company to close on a thinner cash cushion.
- Short-term (Q4 2026): Karman Line Acquisition Corp, the latest aerospace/defense-focused SPAC, filed for a $200M IPO targeting defense and space infrastructure targets — evidence the lane is widening, not narrowing.
- Long-term (1–3 years): Counter-UAS TAM compounds at ~18–22% CAGR across major forecasters, with $24B–$55B endpoints. If Space-Eyes lands even 1% market share on a $30B 2030 base, that's $300M revenue — versus the $1M it's pricing on today. The optionality is real but binary.
- Long-term (1–3 years): Whether Trump-family affiliation becomes a Trump premium or Trump discount depends on political outcomes. An adverse ethics ruling, a change in administration, or a high-profile deal collapse could compress the entire small-cap Trump-affiliated defense bucket by 30–50% in days.
The synthesis
Affiliation is the moat — until it isn't
Space-Eyes is a $1M-revenue, $638M-equity-value company whose investment thesis rests on three layered bets: that counter-UAS demand compounds at 18%+ CAGR, that the firm's CATE fusion engine is differentiated enough to capture a sliver of it, and that Eric Trump's role accelerates the contract pipeline. The Reuters reporting establishes the first two facts but also the third: Eric Trump is already the third-largest private investor and helped introduce board candidates — a structural advantage a non-affiliated rival cannot replicate.
That advantage, however, is the same mechanism that exposes the deal. With $3.2B in direct Pentagon cash and $6.3B total flowing to Trump-sons-linked names, any single ethics ruling, congressional inquiry, or electoral outcome could reprice this entire bucket at once. Investors underwriting CUAS at the deal price are implicitly underwriting the durability of the Trump premium itself — not just the underlying RF-fusion business.
Investable names tied to the Space-Eyes SPAC and the Trump-defense lane
- Pure-play autonomous tactical drone platform competing in the same counter-UAS lane Space-Eyes targets, with $1.42B TTM revenue giving it a 82× scale advantage; Space-Eyes' $35M contract pipeline is a single-quarter shift to KTOS if it lands.
- Trades at ~6× EV/sales vs. Space-Eyes' ~370× post-money — a comparison the McKinley deal forces onto every sell-side defense-tech model over Q4 2026.
- Risk: any Pentagon shift away from component-rich primes back toward integrated software layers (where Space-Eyes plays) compresses KTOS's gross margin (21.8% TTM) over the next 2–4 quarters.
- Counter-UAS already contributes ~$200M of FY26 revenue and management's $3.5B–$4B FY30 revenue target — Space-Eyes pricing validates the segment multiple even if the SPAC itself performs poorly.
- Carries $1.45B working capital and 4.3× current ratio vs. Space-Eyes' pre-revenue profile, making it the conservative proxy for the same thesis.
- Upside: a Q4 2026 Space-Eyes close without redemption blowup reframes AVAV's $7.6B mkt cap as cheap on a 2030E sales basis — analyst PT of $225.77 implies ~50% upside that the SPAC confirms.
- Trump Jr.–linked NDAA-compliant drone component maker; the Space-Eyes deal lifts the entire Trump-affiliated small-cap bucket by confirming family-backed defense IPOs can clear.
- $12.8M Army order + $30M Powerus stake give UMAC upside if Space-Eyes wins Caribbean DHS counter-drone work (RF components flow through suppliers like UMAC).
- Risk: at $691M mkt cap on $17.3M TTM revenue (~40× sales), UMAC already trades at the same speculative multiple as the CUAS deal — meaning the Trump-premium is already partially priced in.
- American Robotics subsidiary builds Scout Drone + ScoutBase; Ondas' FullMAX SDR overlaps the RF-spectrum layer Space-Eyes' Morpheus C-UAS exploits.
- $30M multi-year Israeli demining contract (April 2026) + Palantir partnership (March 2026) put Ondas in direct competition for the same DHS/DOD RF-fusion dollars.
- Watch catalyst: Q3 2026 earnings (early November) — a sub-50% YoY revenue beat or guidance miss forces the market to ask whether Trump-affiliated SPAC demand is firm-specific or sector-wide.
- The shell that absorbed XTEND in the $1.5B July 2026 re-announcement; expected post-merger ticker XTND.
- Single best precedent for what the McKinley/Space-Eyes deal will deliver: XTEND cleared Phase II of the Pentagon's $1B Drone Dominance Program before its Nasdaq debut, raising the bar for Space-Eyes' Q4 contract signings.
- Watch: if XTEND's first 90 days of trading print at a premium to NAV, it confirms the family-affiliated defense-SPAC lane is investable; if it slips below $10, CUAS faces the same trap at close.
- Tradeable until Q4 2026 close at the $10.29 close price reported July 2026; the spread between MKLYU and CUAS post-close is the cleanest read on whether the market believes Space-Eyes hits its $35M contract target.
- Redemption rate at the special meeting is the single binary catalyst: above 60% redemptions shrinks the cash cushion and likely forces a re-priced PIPE.
- Holds 100% cash in trust per SPAC Research, so floor value is intact — but upside is capped unless the deal prints with low redemptions.
